Monti, Elisa; Galvani, Giuseppe; Leoni, Ilaria; Vianello, Clara; Bella, Marco; D’Amico, Federica; Roggiani, Sara; Elena Cifarelli, Maria; Marinelli, Sara; Giovannini, Catia; Gramantieri, Laura; Stefanelli, Claudio; Turroni, Silvia; Fornari, Francesca, Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement, in: SIC 2025 Abstract Book, 2025(atti di: 65th Annual Meeting of the Italian Cancer Society - Targeting cancer hallmarks, Torino, 3-5 dicembre 2025) [Poster]
Monti, E.; Vianello, C.; Leoni, I.; Galvani, G.; Lippolis, A.; D'Amico, F.; Roggiani, S.; Stefanelli, C.; Turroni, S.; Fornari, F., Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies, «CELLS», 2025, 14, Article number: 84 , pp. 1 - 30 [Scientific article]Open Access
Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Pincigher, Luca; Grolla, Ambra A; Moro, Marianna; Coada, Camelia A; Perrone, Alessandro; Righi, Valeria; Marinelli, Sara; Ravegnini, Gloria; Giovannini, Catia; Baldassarre, Maurizio; Pariali, Milena; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Domenicali, Marco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca, MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2025, 26, Article number: 3808 , pp. 1 - 25 [Scientific article]Open Access
Leoni, Ilaria; Vianello, Clara; Monti, Elisa; Galvani, Giuseppe; Bella, Marco; Coada, Camelia Alexandra; Amy, Collins; Erik, Ramon-Gil; Ravegnini, Gloria; Piscaglia, Fabio; Stefanelli, Claudio; Gramantieri, Laura; Jack, Leslie; Mann Derek, A.; Fornari, Francesca, Mir-30e-3p/CXCL3 axis is involved in sorafenib resistance of hepatocellular carcinoma
through the modulation of the tumor immune microenvironment, in: Abstract Book - 65th Annual Meeting of the Italian Cancer Society: Targeting Cancer Hallmarks, 2025(atti di: 65th Annual Meeting of the Italian Cancer Society: Targeting Cancer Hallmarks, Torino, 03-05/12/2025) [Poster]
Monti, Elisa; Vianello, Clara; Leoni, Ilaria; Galvani, Giuseppe; Marinelli, Sara; Marisi, Giorgia; Casadei Giardini, Andrea; Giuseppe Foschi, Francesco; Giovannini1, Catia; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca, miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment, in: Abstract Book EASL meeting 2025, 2025(atti di: European Association for the Study of Liver (EASL) meeting 2025, Amsterdam, 7-10 maggio 2025) [Poster]
Vianello, Clara; Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Marinelli, Sara; Marisi, Giorgia; Casadei Giardini, Andrea; Giuseppe Foschi, Francesco; Giovannini, Catia; 3, ; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca, miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients., in: EASL Liver Cancer Summit 2025 - Abstract Book, 2025(atti di: EASL Liver Cancer Summit 2025, Parigi, 20-22 Febbraio 2025) [Poster]
Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marinelli, S.; Marisi, G.; Casadei Gardini, A.; Foschi, G. F.; Giovannini, C.; Ravaioli, M.; Cescon, M.; Vasuri, F.; Negrini, M.; Piscaglia, F.; Stefanelli, C.; Gramantieri, L.; Fornari, F., CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients., in: Abstract Book AISF Annual Meeting 2024, 2024(atti di: 56th Annual Meeting of the Italian Association for the Study of the Liver, Roma, 14-15 Marzo 2024) [Poster]
Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Marinelli, Sara; Giovannini, Catia; Baldassarre, Maurizio; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Domenicali, Marco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca, MiR-22 downregulation activates HIF-1A pathway and induces tumour progression,
metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma, in: Abstract Book - EASL Liver Cancer Summit 2024, 2024(atti di: EASL Liver Cancer Summit 2024, Rotterdam, Netherlands, 22-24/02/2024) [Poster]
Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marisi, G.; Casadei Gardini, A.; Foschi, G. F.; Stefanelli, C.; Gramantieri, L.; Fornari, F., miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients., in: Abstract Book EACR 2024, 2024(atti di: European Association for Cancer Research (EACR) congress 2024, Rotterdam, 10-13 giugno 2024) [Poster]
Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Fabio Piscaglia, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari, Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response, «CANCERS», 2024, 16, Article number: 766 , pp. 1 - 29 [Scientific article]Open Access
Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Pincigher, Luca; Marinelli, Sara; Ravegnini, Gloria; Giovannini, Catia; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca, The tumour suppressor miR-22 induces metabolic reprogramming through
GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular
Carcinoma, in: Abstract Book - 64nd Annual Meeting of the Italian Cancer Society: Science-driven approaches to achieve early diagnosis of cancer and to overcome therapy resistance, 2024, pp. 45 - 45 (atti di: 64nd Annual Meeting of the Italian Cancer Society: Science-driven approaches to achieve early diagnosis of cancer and to overcome therapy resistance, Milano, 25-27/09/2024) [Contribution to conference proceedings]
Monti, Elisa; Leoni, Ilaria; Galvani, Giuseppe; Vianello, Clara; Giovannini, Catia; Vasuri, Francesco; Piscaglia, Fabio; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca, Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma, in: Abstract Book EACR 2024, 2024(atti di: European Association for Cancer Research (EACR) congress 2024, Rotterdam, 10-13 giugno 2024) [Poster]
Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, Camelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca, MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2023, 42, Article number: 145 , pp. 1 - 23 [Scientific article]Open Access
Leoni, Ilaria; Galvani, Giuseppe; Bergamini, Christian; Rizzardi, Nicola; Melli, Mattia; Coada, Camelia Alexandra; Monti, Elisa; Giovannini, Catia; Liparulo, Irene; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca, MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib
response in hepatocellular carcinoma, in: Abstract Book - EASL Liver Cancer Summit 2023, 2023(atti di: EASL Liver Cancer Summit 2023, Estoril, Portugal, 20-22/04/2023) [Poster]
Gramantieri, Laura; Leoni, Ilaria; Pollutri, Daniela; Galvani, Giuseppe; Giovannini, Catia; Suzzi, Fabrizia; Casadei-Gardini, Andrea; Callegari, Elisa; Vasuri, Francesco; Ravaioli, Matteo; Cescon, Matteo; Piscaglia, Fabio; Negrini, Massimo; Fornari, Francesca, MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to
sorafenib Treatment, in: Abstract Book - 62nd Annual Meeting of the Italian Cancer Society: The exciting path from preclinical research to clinical application, 2022(atti di: 62nd Annual Meeting of the Italian Cancer Society: The exciting path from preclinical research to clinical application, Venezia, 16-18/11/2022) [Poster]
